Asparaginase
Showing 26 - 50 of 292
Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)
Not yet recruiting
- Lymphoblastic Leukemia
- Dexamethasone
- +8 more
-
Palo Alto, CaliforniaStanford University
Apr 27, 2023
T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,
Not yet recruiting
- T-cell Lymphoblastic Lymphoma
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
-
Shanghai, Shanghai, China
- +1 more
Dec 27, 2022
Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)
Recruiting
- Acute Lymphoblastic Leukemia
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 2, 2023
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in
Not yet recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +6 more
- Biopsy
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Apr 26, 2022
Acute Lymphoblastic Leukemia Trial in Canada, United States (Doxorubicin, Cytarabine, Methotrexate)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- Doxorubicin
- +13 more
-
Boston, Massachusetts
- +14 more
Jul 25, 2022
Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia
Recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- +3 more
- Cyclophosphamide
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2022
Extranodal NK/T-cell Lymphoma Trial in Bangkok (B-MAD chemo)
Active, not recruiting
- Extranodal NK/T-cell Lymphoma
- B-MAD chemotherapy
-
Bangkok, ThailandKing Chulalongkorn Memorial Hospital
May 7, 2022
B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin
Recruiting
- B Acute Lymphoblastic Leukemia
- Ph-Like Acute Lymphoblastic Leukemia
- Cyclophosphamide
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 26, 2022
T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)
Recruiting
- T Acute Lymphoblastic Leukemia
- T Lymphoblastic Lymphoma
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Jan 11, 2023
Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,
Completed
- Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood B-Lymphoblastic Lymphoma
- dexamethasone
- +18 more
-
San Diego, California
- +2 more
Sep 13, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)
Recruiting
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Rituximab
- +18 more
-
Frankfurt (Main), GermanyUniversity Hospital of Frankfurt (Main)
Jul 1, 2022
Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,
Completed
- Drug/Agent Toxicity by Tissue/Organ
- Leukemia
- asparaginase
- +15 more
-
Boston, Massachusetts
- +9 more
Nov 9, 2022
Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)
Terminated
- Acute Lymphocytic Leukemia
- Adult Lymphoblastic Lymphoma
- DNR
- +12 more
-
La Jolla, California
- +3 more
Apr 26, 2022
Acute Myeloid Leukemia Trial in France (GRASPA)
Completed
- Acute Myeloid Leukemia
-
Nice, Alpes Maritimes, France
- +20 more
Feb 18, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Canada, United States (asparaginase Erwinia chrysanthemi)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- asparaginase Erwinia chrysanthemi
-
Los Angeles, California
- +21 more
Jun 1, 2021
Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)
Completed
- Acute Lymphoblastic Leukemia
- Everolimus
- +5 more
-
San Francisco, California
- +7 more
Aug 5, 2022
Acute Lymphoblastic Leukemia(ALL)
Completed
- Acute Lymphoblastic Leukemia
-
Aalborg, Denmark
- +3 more
Jan 12, 2021
Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia Trial in United States (ABT-751, Dexamethasone,
Terminated
- Recurrent Pediatric ALL
- +3 more
- ABT-751
- +7 more
-
Los Angeles, California
- +4 more
Feb 22, 2021
NK/T Cell Lymphoma Trial in Singapore (IV Nivolumab, IV Gemcitabine, IV Cisplatin)
Withdrawn
- NK/T Cell Lymphoma
- IV Nivolumab
- +4 more
-
Singapore, SingaporeNational Cancer Centre Singapore
Nov 3, 2020
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Trial in Shanghai (Anlotinib)
Completed
- Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
-
Shanghai, ChinaXinhua Hospital
Sep 13, 2021
Extranodal NK-T-Cell Lymphoma Trial in Seoul (Etoposide, Ifosfamide, Dexamethasone)
Unknown status
- Extranodal NK-T-Cell Lymphoma
- Etoposide
- +5 more
-
Seoul, Seoul, Korea, Republic Of, Korea, Republic of
- +1 more
Oct 21, 2020
Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer Trial in Worldwide (Daunorubicin, Prednisolone, Vincristine)
Recruiting
- Down Syndrome
- +2 more
- Daunorubicin
- +9 more
-
Shatin, New Territories, Hong Kong
- +9 more
Sep 26, 2022